Cantargia Financial Statements From 2010 to 2024
| CANTA Stock | SEK 1.81 0.05 2.69% |
Check Cantargia financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cantargia's main balance sheet or income statement drivers, such as , as well as many indicators such as . Cantargia financial statements analysis is a perfect complement when working with Cantargia Valuation or Volatility modules.
Cantargia |
Cantargia AB Company Shares Outstanding Analysis
Cantargia's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Cantargia Shares Outstanding | 166.99 M |
Most of Cantargia's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cantargia AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, Cantargia AB has 166.99 M of shares currently outstending. This is 7.5% lower than that of the Healthcare sector and 56.28% higher than that of the Biotechnology industry. The shares outstanding for all Sweden stocks is 70.8% higher than that of the company.
Cantargia AB Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Cantargia's current stock value. Our valuation model uses many indicators to compare Cantargia value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Cantargia competition to find correlations between indicators driving Cantargia's intrinsic value. More Info.Cantargia AB is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Cantargia's earnings, one of the primary drivers of an investment's value.About Cantargia Financial Statements
Cantargia shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Cantargia investors may analyze each financial statement separately, they are all interrelated. The changes in Cantargia's assets and liabilities, for example, are also reflected in the revenues and expenses on on Cantargia's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Cantargia AB , a biotechnology company, engages in the research and development of antibody-based treatments for life threatening diseases. Cantargia AB was founded in 2010 and is based in Lund, Sweden. Cantargia operates under Pharmaceuticals And Biosciences classification in Sweden and is traded on Stockholm Stock Exchange. It employs 19 people.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Cantargia Stock Analysis
When running Cantargia's price analysis, check to measure Cantargia's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cantargia is operating at the current time. Most of Cantargia's value examination focuses on studying past and present price action to predict the probability of Cantargia's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cantargia's price. Additionally, you may evaluate how the addition of Cantargia to your portfolios can decrease your overall portfolio volatility.